ocular infection, genomic surveillance, WGS, ONT, AMR, ST395, ST231, ARGs, NDM, plasmids, HGT, LMIC
COVID-19, Vaccine trial, homologous booster, heterologous booster, ChAdOx1 nCoV-19, COVISHIELD, BBV152, COVAXIN, immunogenicity, safety